Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of coenzyme Q10 in statin myopathy.
Zlatohlavek L, Vrablik M, Grauova B, Motykova E, Ceska R. Zlatohlavek L, et al. Neuro Endocrinol Lett. 2012;33 Suppl 2:98-101. Neuro Endocrinol Lett. 2012. PMID: 23183519 Clinical Trial.
COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
Hubacek JA, Adamkova V, Zlatohlavek L, Steiner-Mrazova L, Vrablik M. Hubacek JA, et al. Among authors: zlatohlavek l. Drug Metab Pers Ther. 2017 Dec 20;32(4):177-182. doi: 10.1515/dmpt-2017-0027. Drug Metab Pers Ther. 2017. PMID: 29257754 Clinical Trial.
SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA, Dlouhá D, Adámková V, Zlatohlavek L, Viklický O, Hrubá P, Češka R, Vrablík M. Hubáček JA, et al. Among authors: zlatohlavek l. Med Sci Monit. 2015 May 20;21:1454-9. doi: 10.12659/MSM.893007. Med Sci Monit. 2015. PMID: 25992810 Free PMC article.
Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children.
Motykova E, Zlatohlavek L, Prusikova M, Lanska V, Ceska R, Vasickova L, Vrablik M. Motykova E, et al. Neuro Endocrinol Lett. 2011;32 Suppl 2:55-9. Neuro Endocrinol Lett. 2011. PMID: 22101884
APOE polymorphism as a potential determinant of functional fitness in the elderly regardless of nutritional status.
Snejdrlova M, Kalvach Z, Topinkova E, Vrablik M, Prochazkova R, Kvasilova M, Lanska V, Zlatohlavek L, Prusikova M, Ceska R. Snejdrlova M, et al. Neuro Endocrinol Lett. 2011;32 Suppl 2:51-4. Neuro Endocrinol Lett. 2011. PMID: 22101883
[Statin pharmacokinetics].
Hubácek JA, Adámková V, Zídková K, Ceska R, Zlatohlávek L, Stulc T, Horínek A, Vrablík M. Hubácek JA, et al. Vnitr Lek. 2008 Jan;54(1):62-7. Vnitr Lek. 2008. PMID: 18390119 Review. Czech.
Statin-induced changes in mitochondrial respiration in blood platelets in rats and human with dyslipidemia.
Vevera J, Fišar Z, Nekovářová T, Vrablík M, Zlatohlávek L, Hroudová J, Singh N, Raboch J, Valeš K. Vevera J, et al. Among authors: zlatohlavek l. Physiol Res. 2016 Nov 23;65(5):777-788. doi: 10.33549/physiolres.933264. Epub 2016 Jul 15. Physiol Res. 2016. PMID: 27429121 Free article.
Statin-associated myopathy: from genetic predisposition to clinical management.
Vrablik M, Zlatohlavek L, Stulc T, Adamkova V, Prusikova M, Schwarzova L, Hubacek JA, Ceska R. Vrablik M, et al. Physiol Res. 2014;63(Suppl 3):S327-34. doi: 10.33549/physiolres.932865. Physiol Res. 2014. PMID: 25428737 Review.
Impact of variants within seven candidate genes on statin treatment efficacy.
Vrablík M, Hubáček JA, Dlouhá D, Lánská V, Rynekrová J, Zlatohlávek L, Prusíková M, Ceška R, Adámková V. Vrablík M, et al. Physiol Res. 2012;61(6):609-17. doi: 10.33549/physiolres.932341. Epub 2012 Oct 25. Physiol Res. 2012. PMID: 23098650
Statin treatment resulted in a significant decrease of both total cholesterol (7.00+/-1.53-->5.15+/-1.17 mmol/l, P<0.0001) and triglycerides (2.03+/-1.01-->1.65+/-1.23 mmol/l, P<0.0005). ...
Statin treatment resulted in a significant decrease of both total cholesterol (7.00+/-1.53-->5.15+/-1.17 mmol/l, P<0.0001) and …
29 results
Jump to page
Feedback